Acquisition by Bennett Roy Edwin of 4624 shares of Atmus Filtration subject to Rule 16b-3
| ATMU Stock | 38.97 0.22 0.56% |
Slightly above 61% of Atmus Filtration's investor base is looking to short. The analysis of overall sentiment of trading Atmus Filtration Technologies stock suggests that many investors are alarmed at this time. Atmus Filtration's investing sentiment can be driven by a variety of factors including economic data, Atmus Filtration's earnings reports, geopolitical events, and overall market trends.
Atmus |
Filed transaction by Atmus Filtration Technolo director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Atmus Filtration Fundamental Analysis
We analyze Atmus Filtration's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atmus Filtration using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atmus Filtration based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Atmus Filtration is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Atmus Filtration Tec Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atmus Filtration stock to make a market-neutral strategy. Peer analysis of Atmus Filtration could also be used in its relative valuation, which is a method of valuing Atmus Filtration by comparing valuation metrics with similar companies.
Peers
Atmus Filtration Related Equities
| ABCL | Abcellera Biologics | 3.55 | ||||
| TARS | Tarsus Pharmaceuticals | 3.08 | ||||
| RBC | RBC Bearings | 0.02 | ||||
| CPRX | Catalyst Pharmaceuticals | 1.06 | ||||
| SYRE | Spyre Therapeutics | 2.87 | ||||
| ABOS | Acumen Pharmaceuticals | 2.99 | ||||
| GNFT | Genfit | 3.83 |
Additional Tools for Atmus Stock Analysis
When running Atmus Filtration's price analysis, check to measure Atmus Filtration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atmus Filtration is operating at the current time. Most of Atmus Filtration's value examination focuses on studying past and present price action to predict the probability of Atmus Filtration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atmus Filtration's price. Additionally, you may evaluate how the addition of Atmus Filtration to your portfolios can decrease your overall portfolio volatility.